• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA delays decision on Sanofi, Zealand’s diabetes drug, handing lead to Novo Nordisk


<















$245 million down the drain.

Not to mention the $200 million+ we spent on the Praulent voucher.

There is some bad stuff coming soon. You shouldn't be surprised when the do-do hits the fan. Prepare yourselves people. There is a Tsunami on the horizon and you can't outrun it.

This should be the theme song at next launch meeting.

Another one bites the dust
Another one bites the dust
And another one gone, and another one gone
Another one bites the dust
Hey, I'm gonna get you too
Another one bites the dust
 




Similar threads